Atopic Dermatitis Technology
Current treatments for atopic dermatitis (a chronic inflammatory skin disease) only treat the symptoms and not the root cause of the disease. 360ip’s partner has developed a novel treatment that is able to suppress and inhibit the disease, targeting the root cause rather than just treating symptoms. The compound developed by the partner has the following key advantages:
Suppresses fibroinflammation by targeting discoidin domain receptor tyrosine kinase
Current treatments only inhibit inflammation
Inhibits fibrotic cell migration
Inhibits focal adhesion & actin stress fiber
Inhibits cell invasion and Akt1 activation
Suppresses activated macrophage signaling